SDAM
Shulman DeMeo Asset Management’s GSK GSK Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-10,764
| Closed | -$469K | – | 132 |
|
2022
Q2 | $469K | Buy |
10,764
+492
| +5% | +$21.4K | 0.16% | 63 |
|
2022
Q1 | $447K | Buy |
10,272
+42
| +0.4% | +$1.83K | 0.12% | 81 |
|
2021
Q4 | $451K | Buy |
+10,230
| New | +$451K | 0.12% | 78 |
|
2021
Q3 | – | Sell |
-9,790
| Closed | -$390K | – | 102 |
|
2021
Q2 | $390K | Buy |
9,790
+42
| +0.4% | +$1.67K | 0.15% | 43 |
|
2021
Q1 | $348K | Buy |
9,748
+4
| +0% | +$143 | 0.09% | 98 |
|
2020
Q4 | $359K | Buy |
9,744
+91
| +0.9% | +$3.35K | 0.1% | 92 |
|
2020
Q3 | $363K | Sell |
9,653
-306
| -3% | -$11.5K | 0.12% | 78 |
|
2020
Q2 | $406K | Sell |
9,959
-557
| -5% | -$22.7K | 0.16% | 65 |
|
2020
Q1 | $398K | Sell |
10,516
-691
| -6% | -$26.2K | 0.19% | 54 |
|
2019
Q4 | $527K | Sell |
11,207
-271
| -2% | -$12.7K | 0.18% | 61 |
|
2019
Q3 | $490K | Buy |
11,478
+31
| +0.3% | +$1.32K | 0.16% | 64 |
|
2019
Q2 | $458K | Buy |
11,447
+37
| +0.3% | +$1.48K | 0.17% | 63 |
|
2019
Q1 | $477K | Buy |
11,410
+32
| +0.3% | +$1.34K | 0.18% | 57 |
|
2018
Q4 | $435K | Buy |
+11,378
| New | +$435K | 0.24% | 37 |
|